Cyclerion Therapeutics Statistics
Total Valuation
CYCN has a market cap or net worth of $9.36 million. The enterprise value is $1.79 million.
Market Cap | 9.36M |
Enterprise Value | 1.79M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, before market open.
Earnings Date | May 10, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CYCN has 2.71 million shares outstanding. The number of shares has increased by 7.59% in one year.
Shares Outstanding | 2.71M |
Shares Change (YoY) | +7.59% |
Shares Change (QoQ) | -11.88% |
Owned by Insiders (%) | 20.77% |
Owned by Institutions (%) | 41.34% |
Float | 1.13M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.83 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.85, with zero debt.
Current Ratio | 3.85 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 15.70 |
Financial Efficiency
Return on equity (ROE) is -63.30% and return on invested capital (ROIC) is -114.73%.
Return on Equity (ROE) | -63.30% |
Return on Assets (ROA) | -42.00% |
Return on Capital (ROIC) | -114.73% |
Revenue Per Employee | n/a |
Profits Per Employee | -$5.26M |
Employee Count | 1 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.20% in the last 52 weeks. The beta is 1.83, so CYCN's price volatility has been higher than the market average.
Beta (1Y) | 1.83 |
52-Week Price Change | -53.20% |
50-Day Moving Average | 3.12 |
200-Day Moving Average | 3.23 |
Relative Strength Index (RSI) | 51.65 |
Average Volume (30 Days) | 2,950 |
Short Selling Information
The latest short interest is 22,052, so 0.81% of the outstanding shares have been sold short.
Short Interest | 22,052 |
Short Previous Month | 23,488 |
Short % of Shares Out | 0.81% |
Short % of Float | 1.95% |
Short Ratio (days to cover) | 9.25 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -12.95M |
Pretax Income | -5.26M |
Net Income | -5.26M |
EBITDA | -5.62M |
EBIT | -5.62M |
Earnings Per Share (EPS) | -$2.25 |
Balance Sheet
The company has $7.57 million in cash and no debt, giving a net cash position of $7.57 million or $2.79 per share.
Cash & Cash Equivalents | 7.57M |
Total Debt | n/a |
Net Cash | 7.57M |
Net Cash Per Share | $2.79 |
Equity / Book Value | 11.29M |
Book Value Per Share | 4.17 |
Working Capital | 5.94M |
Cash Flow
Operating Cash Flow | -21.25M |
Capital Expenditures | n/a |
Free Cash Flow | -21.25M |
FCF Per Share | -$9.09 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CYCN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -7.59% |
Shareholder Yield | -7.59% |
Earnings Yield | -56.22% |
FCF Yield | -226.95% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 16, 2023. It was a reverse split with a ratio of 1:20.
Last Split Date | May 16, 2023 |
Split Type | Reverse |
Split Ratio | 1:20 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |